| Autor: |
George Athanasios Karpouzas, Eirik Ikdahl, Silvia Rollefstad, Grunde Wibetoe, Anne Grete Semb, Joseph Sexton, Patrick Durez, Maria G Tektonidou, Michal Tomčík, Dionicio Angel Galarza-Delgado, Ian Graham, Miguel A González-Gay, Solbritt Rantapää-Dahlqvist, Erkin M Mirrakhimov, Petros P Sfikakis, Virginia Pascual-Ramos, Carol Hitchon, Maria Simona Stoenoiu, Elena Myasoedova, Durga Prasanna Misra, Vikas Agarwal, Dimitrios Vassilopoulos, Piet van Riel, Bindee Kuriya, George Kitas, Rong Mu, Anne M Kerola, Karen Douglas, Andrew A Borg, Pompilio Faggiano, Cindy Crowson, Argyro Lazarini, Diane Gheta, Svetlana Myasoedova, Lev Krougly, Tatiana Valentinovna Popkova, Alena Tuchyňová, Michal Vrablik, Pavel Horak, Helena Kaspar Medkova |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
RMD Open, Vol 7, Iss 2 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2056-5933 |
| DOI: |
10.1136/rmdopen-2021-001724 |
| Popis: |
Aim The objective was to examine the prevalence of atherosclerotic cardiovascular disease (ASCVD) and its risk factors among patients with RA with diabetes mellitus (RA-DM) and patients with RA without diabetes mellitus (RAwoDM), and to evaluate lipid and blood pressure (BP) goal attainment in RA-DM and RAwoDM in primary and secondary prevention.Methods The cohort was derived from the Survey of Cardiovascular Disease Risk Factors in Patients with Rheumatoid Arthritis from 53 centres/19 countries/3 continents during 2014–2019. We evaluated the prevalence of cardiovascular disease (CVD) among RA-DM and RAwoDM. The study population was divided into those with and without ASCVD, and within these groups we compared risk factors and CVD preventive treatment between RA-DM and RAwoDM.Results The study population comprised of 10 543 patients with RA, of whom 1381 (13%) had DM. ASCVD was present in 26.7% in RA-DM compared with 11.6% RAwoDM (p |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
